Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_assertion description "[The purpose is to study the prognostic significance of tissue expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor (TATI) and serum concentration of trypsinogen-2, trypsin-2-API (complex of trypsin-2 with alpha-1-proteinase inhibitor), and TATI in epithelial ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_assertion evidence source_evidence_literature NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_assertion SIO_000772 15269150 NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_assertion wasDerivedFrom befree-20150227 NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_assertion wasGeneratedBy ECO_0000203 NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP226035.RAfRZqPuc3MP0k_q1i3Z9FepSQoChQAhdDiwPgxY5mkP0130_provenance.